Lanean...
P13.07 Phase II study of systemic high-dose methotrexate and intrathecal liposomal cytarabine for treatment of breast cancer with leptomeningeal metastases
BACKGROUND: Metastatic breast cancer frequently leads to brain metastases and, less commonly, leptomeningeal carcinomatosis (LC). Once cerebro-spinal fluid (CSF) involvement occurs the prognosis is poor with median survival between 3–7 months. There are limited treatment options available, but none...
Gorde:
| Argitaratua izan da: | Neuro Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782744/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.251 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|